Gemmothérapie Stress et Sommeil
Food supplement declared in France, declaration No 2023-10-26
Gemmothérapie Stress et Sommeil, from Floralpina, is a food supplement declared in France. Status: withdrawn from the market on 27 November 2025. Main ingredients: Crataegus laevigata 0.25 ml per day, Ficus carica 0.25 ml per day, Tilia × 0.25 ml per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- Floralpina
- Status
- Withdrawn from the market on 27 November 2025
- Form
- Dropper
- Daily dose
- 10 à 15 gouttes par jour
- Directions for use
- Prendre 10 à 15 gouttes dans un petit verre d'eau 15 mn avant les repas (1 prise par jour).
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep
Declaration 135329, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Crataegus laevigata (Poir.) DC. | Bourgeon | Macérât hydroglycériné | 0.25 ml |
| Ficus carica L. | Bourgeon | Macérât hydroglycériné | 0.25 ml |
| Tilia × europaea L. | Feuille | Macérât hydroglycériné | 0.25 ml |
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Tenir hors de portée des jeunes enfants.Ne pas dépasser la dose conseillée.A consommer dans le cadre d'une alimentation variée et équilibrée et d'un mode de vie sain.Conserver le flacon bien fermé dans un endroit frais et à l'abri de la lumière.Déconseillé chez les femmes enceintes ou allaitantes et chez les enfants.
Regulatory points
- Information
Withdrawn from the market on 27 November 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Crataegus laevigata (Poir.) DC.
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Gemmothérapie Stress et Sommeil: composition and regulation”, https://compoatlas.com/en/supplements/products/135329-gemmotherapie-stress-et-sommeil, updated 15 November 2026.